title: Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?
authors.affiliation: Tata Memorial Hospital, Mumbai, India. sudeepgupta04@yahoo.com
authors.forename: Sudeep
authors.initials: S
authors.lastname: Gupta
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016190:Carboplatin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D016019:Survival Analysis
chemical_list: D015251:Epirubicin; D016190:Carboplatin; D017239:Paclitaxel